GlassScriptPhysician profile
Anthony T Giuffrida
NPI 1740624451
$270,872.95
in general payments reported to CMS, 2019-2025
39 companies · $8,224 in 2025
The $8,224 reported for 2025 was more than what 98% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $21K · 2021: $27K · 2022: $92K · 2023: $38K · 2024: $49K · 2025: $8,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Consulting Fee: $29K · Travel and Lodging: $13K · Food and Beverage: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Education: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,012.50 |
| Consulting Fee | $28,747.50 |
| Travel and Lodging | $13,262.94 |
| Food and Beverage | $12,239.29 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Education | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $110,451.91 | 2019-2023 | Intracept |
| Mml US, INC. | $110,128.62 | 2021-2025 | Reactiv8 |
| Nevro Corp. | $17,644.90 | 2019-2024 | Senza, Vyrsa V1, Omnia |
| Boston Scientific Corporation | $9,238.82 | 2021-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $8,005.35 | 2020-2023 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $2,689.03 | 2019-2020 | |
| Interventional Pain Technologies INC. | $2,563.01 | 2022-2023 | Vyrsa V1 |
| Lenoss Medical INC | $2,213.25 | 2024 | Access & Cavity Creation Kit |
| Stryker Corporation | $1,457.94 | 2019-2025 | Augment Injectable, Mild Device Kit, Optablate |
| Abbott Laboratories | $1,114.55 | 2019-2025 | Proclaim, Eterna |
| Averitas Pharma INC. | $731.07 | 2023-2025 | Qutenza |
| Vertiflex, INC. | $645.31 | 2019 | |
| Saluda Medical Americas, INC. | $564.11 | 2022-2024 | Evoke Scs, Evoke |
| Depuy Synthes Sales INC. | $456.42 | 2019-2023 | Skyline, Vivigen Mis Delivery System, Teligen |
| Medtronic, INC. | $406.95 | 2021-2024 | Intellis Adaptivestim |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Fusion Solutions, LLC | $368.16 | 2020 | |
| Nalu Medical, INC. | $360.02 | 2021-2022 | |
| Stimwave Technologies Incorporated | $332.74 | 2020-2022 | |
| Vertos Medical, INC. | $289.49 | 2023-2024 | Mild Device Kit |
| Nuvasive, INC. | $275.20 | 2019-2023 | Tlif, Acp, Tlx |
| Globus Medical, INC. | $140.52 | 2025 | Vyrsa V1, Senza, Hedron |
| Curonix LLC | $126.28 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stratus Medical, LLC | $121.67 | 2022 | |
| Horizon Therapeutics Plc | $92.91 | 2022 | |
| Biocomposites INC | $89.93 | 2024 | |
| Spr Therapeutics, INC | $70.49 | 2022 | |
| Orthofix Medical, INC. | $50.37 | 2023 | Spinal-Stim, Spinal-Stim |
| Vertex Pharmaceuticals Incorporated | $47.69 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $32.57 | 2025 | Iovera |
| Scilex Pharmaceuticals INC. | $24.45 | 2022 | |
| Grt US Holding, INC. | $23.74 | 2022 | |
| Kci USA, INC. | $20.94 | 2020 | |
| Baxter Healthcare | $17.58 | 2021 | |
| The Institute of Musculoskeletal Science and Education | $16.67 | 2023 | |
| Assertio Therapeutics, INC. | $16.05 | 2019 | |
| Smith+Nephew, INC. | $15.28 | 2020 | |
| Olympus America INC. | $14.89 | 2024 | Evis X1 Video System Center |
| Si-Bone, INC. | $14.07 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$478,562.91 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Giuffrida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.